Books by Subject

Substance-Related Disorders

  • 2016From: OSO
    edited by Nick Heather, Gabriel Segal.
    The central problem in the study of addiction is to explain why people repeatedly behave in ways they know are bad for them. For much of the previous century and until the present day, the majority of scientific and medical attempts to solve this problem were couched in terms of involuntary behaviour; if people behave in ways they do not want, then this must be because the behaviour is beyond their control and outside the realm of choice. An opposing tradition, which finds current support among scientists and scholars as well as members of the general public, is that so-called addictive behavior reflects an ordinary choice just like any other and that the concept of addiction is a myth. The editors and authors of this book tend to take neither view. There has been an increasing recognition in recent literature on addiction that restricting possible conceptions of it to either of these extreme positions is unhelpful and is retarding progress on understanding the nature of addiction and what could be done about it.This book contains a range of views from philosophy, neuroscience, psychiatry, psychology and the law on what exactly this middle ground between free choice and no choice consists of and what its implications are for theory, practice and policy on addiction. The result amounts to a profound change in our thinking on addiction and how its devastating consequences can be ameliorated. Addiction and Choice is a thought provoking new volume for all those with an interest in this global issue.
  • 2008From: CRCnetBASE
    edited by Steven B. Karch.
    The Principles of addiction medicine / Duncan Raistrick -- Substitute prescribing : opioid-specific prescribing / Kim Wolff -- Substitute prescribing : buprenorphine maintenance prescribing / Nick Lintzeris -- Treatment of withdrawal symptoms / Joanna Banbery -- Replacement prescribing / Kim Wolff -- Management of comorbidity / Duncan Raistrick -- Toxicologic issues / Kim Wolff -- Medical aspects of drug abuse / Shoshana Zevin and Neal L. Benowitz -- Emergency management of drug abuse / Brett A. Roth, Neal L. Benowitz, and Kent R. Olson.
  • 2016From: Oxford Medicine Online
    edited by Maria A. Sullivan and Frances R. Levin.
    An evidence-based review of diagnostic and treatment strategies for successfully managing alcohol and substance use disorders in older adults. With contributions from leaders in the field of addiction treatment, this volume offers the most current clinical recommendations and describes best practices for implementing effective treatments in this growing patient population.
  • 2011From: Springer
    edited by Bankole A. Johnson.
    This book attempts to "bridge the gap between the explosion of neuroscientific and behavioral knowledge in the past three decades and treatment delivery in clinical practice. As such, it should fulfill the role of a comprehensive textbook that integrates addiction medicine from its scientific underpinnings to the treatment of patients in clinical settings"--Preface, p. vii.
  • 2016From: Oxford Medicine Online
    edited by John B. Saunders, Katherine M. Conigrave, Noeline C. Latt, David J. Nutt, E. Jane Marshall, Walter Ling, Susumu Higuchi.
    1. The nature of addictive disorders / John B. Saunders -- 2. Epidemiology and prevention / Peter Anderson, Katherine M. Conigrave, Louisa Degenhardt, Wayne Hall, and Tim Stockwell -- 3. Pharmacology and pathophysiology / Kazutaka Ikeda, Daisuke Nishizawa, David J. Nutt, and John B. Saunders -- 4. The scope of intervention / Sawitri Assanangkornchai and John B. Saunders -- 5. Establishing the diagnosis / Glenys Dore, Noeline C. Latt, and John B. Saunders -- 6. Acute care / Glenys Dore, Noeline C. Latt, E. Jane Marshall, John B. Saunders, and Peter Thompson -- 7. Ongoing management of substance use disorders / Stephen Jurd and John B. Saunders -- 8. Tobacco / Renee Bittoun, Katherine M. Conigrave, Hisatsugu Miyata, and Nicholas Zwar -- 9. Alcohol / Robert Batey, Katherine M. Conigrave, Colin Drummond, Noeline C. Latt, E. Jane Marshall, David J. Nutt, Richard Saitz, and John B. Saunders -- 10. Cannabis / H. Valerie Curran, Margaret Haney, David J. Nutt, and John B. Saunders -- 11. Opioids / Robert Batey, Katherine M. Conigrave, Noeline C. Latt, David J. Nutt, John B. Saunders, Andrew J. Saxon, and George Woody -- 12. Pain and opioids / James Bell -- 13. Benzodiazepines and the other sedative-hypnotics / Noeline C. Latt, David J. Nutt, and John B. Saunders -- 14. Psychostimulants / Glenys Dore, Walter Ling, and David J. Nutt -- 15. Hallucinogens and dissociative drugs / David J. Nutt and Adam R. Winstock -- 16. Other drugs / Jenny Bearn, Jonathan Brett, Adam Brodie, Katherine M. Conigrave, Shivani Khan, Janie Sheridan, Iain Smith, Catherine Woodstock Striley, David Taylor, and Adam R. Winstock -- 17. Polysubstance use / Jason P. Connor and Gerald F. X. Feeney -- 18. Injecting drug use / Robert Batey, Katherine M. Conigrave, Paul Haber, and John Strang -- 19. Gambling / Henrietta Bowden-Jones, Sanju George, Yasunobu Komoto, David J. Nutt, <i>and Taku Sato</i> -- 20. Gaming / Hideki Nakayama and Hiroshi Sakuma -- 21. Other addictive disorders / Takayuki Harada, Susumu Higuchi, Satoko Mihara, and John B. Saunders -- 22. Psychiatric comorbidity / Glenys Dore, Anne Lingford-Hughes, and John B. Saunders -- 23. Specific clinical situations / Noeline C. Latt, John B. Saunders, and Sue Wilson -- 24. Special populations / Sawitri Assanangkornchai, Tatiana Balachova, Yvonne Bonomo, Katherine M. Conigrave, Ilana B. Crome, Glenys Dore, Bradley Freeburn, Marianne Jauncey, Michael Levy, Corinne Lim, Ross McCormick, and Kim Wolff -- 25. Substance use and specific health care settings / Jonathan Brett, Tim Neumann, Richard Saitz, John B. Saunders, Claudia Spies, and Pierluigi Struzzo -- 26. Legal and ethical issues / Katherine M. Conigrave, Glenys Dore, Emily Finch, Ralph Hingson, Noeline C. Latt, Sally Porter, and John B. Saunders.
  • 2012From: ScienceDirect
    edited by Andrian Carter, Wayne Hall, Judy Illes.
    What is addiction neuroethics and why does it matter? -- Brain Imaging in Addiction -- Molecular Neuroscience and Genetics -- Treating Opioid Dependence with Opioids: Exploring the Ethics -- Addiction Neuroscience and Tobacco Control -- Emerging Neurobiological Treatments of Addiction: Ethical and Public Policy Considerations -- Technical, Ethical and Social Issues in the Bioprediction of Addiction Liability and Treatment Response -- Autonomy, Responsibility and the Oscillation of Preference -- Consent and Coercion in Addiction Treatment -- Toward a Lay Descriptive Account of Identity in Addiction Neuroethics -- The Impact of Changes in Neuroscience and Research Ethics on the Intellectual History of Addiction Research -- The Diction of Addiction at the Intersection of Law and Neuroscience -- Social Epistemology: Communicating Neuroscience -- Population Approaches to Alcohol, Tobacco and Drugs: Effectiveness, Ethics and Interplay with Addiction Neuroscience -- Legal Regulation of Addictive Substances and Addiction -- Investment and Vested Interests in Neuroscience Research of Addiction: Ethical Research Requires More than Informed Consent -- Private and Public Approaches to Addiction Treatment: Evidence and Beliefs.
  • 2011From: Springer
    John F. Kelly, William L. White, editors.
    Addiction Recovery Management: Theory, Research, and Practice is the first book on the recovery management approach to addiction treatment and post-treatment support services. Distinctive in combining theory, research, and practice within the same text, this ground-breaking title includes authors who are the major theoreticians, researchers, systems administrators, clinicians and recovery advocates who have developed the model. State-of-the art and the definitive text on the topic, Addiction Recovery Management: Theory, Research, and Practice is mandatory reading for clinicians and all professionals who work with patients in recovery or who are interested in the field.
  • 2013From: Springer
    Richard Saitz, editor.
    "While there is a wealth of published information on addiction medicine, the psychological aspects of alcohol abuse, and behavioral medicine with regard to addiction, virtually none of the existing resources were written with the primary care provider in mind. Addressing Unhealthy Alcohol Use in Primary Care is a handy reference for primary care clinicians who are confronted by patients with these problems daily, and who wish to successfully address these issues in their practice. Focusing on the literature and science relevant to practicing providers, this book covers the range of interventions appropriate for this setting. Topics include assessment, brief counseling interventions, pharmacotherapy, referrals to both specialty care and Alcoholics Anonymous (and other self-help programs), psychiatric comorbidity and other drug use, and other information specific to the needs of the primary care clinician. The vast majority of people with health risks and consequences related to alcohol use receive little to no attention from healthcare, despite the fact that alcohol is a leading cause of early preventable death. This book is a guide to identifying and addressing unhealthy alcohol use in hopes of improving the lives of patients."--publisher's website
  • 2009From: Springer
    Carl G Leukefeld, Thomas P. Gullotta, Michelle Staton-Tindall, editors.
    1 A Selected Social History of the Stepping-Stone Drugs / Thomas P. Gullotta 1 -- 2 A Biological/Genetic Perspective: The Addicted Brain / Thomas H. Kelly, Alessandra N. Kazura, Karen M. Lommel, Shanna Babalonis, Catherine A. Martin 15 -- 3 Individual Characteristics and Needs Associated with Substance Misuse of Adolescents and Young Adults in Addiction Treatment / Michael L. Dennis, Michelle K. White, Melissa L. Ives 45 -- 4 Adolescent Substance Abuse Treatment: A Review of Evidence-Based Research / Ken C. Winters, Andria M. Botzet, Tamara Fahnhorst, Randy Stinchfield, Rachel Koskey 73 -- 5 Adolescent Outpatient Treatment / Richard Dembo, Randolph D. Muck 97 -- 6 Evidence-Based Family Treatment of Adolescent Substance Abuse and Dependence / Shaun I. Calix, Mark A. Fine 119 -- 7 Residential Treatment of Adolescents with Substance Use Disorders: Evidence-Based Approaches and Best Practice Recommendations / Robert W. Plant, Peter Panzarella 135 -- 8 Primary Prevention in Adolescent Substance Abuse / Martin Bloom, Thomas P. Gullotta 155 -- 9 Religious Involvement and Adolescent Substance Use / Terrence D. Hill, Amy M. Burdette, Michael L. Weiss, Dale D. Chitwood 171 -- 10 School Prevention / Zili Sloboda 191 -- 11 Community Prevention Handbook on Adolescent Substance Abuse Prevention and Treatment: Evidence-Based Practices / Elizabeth J. D'Amico, Matthew Chinman, Stefanie A. Stern, Abraham Wandersman 213 -- Epilogue: The Status of Knowledge Development and the Unknown / Michele Staton-Tindall, Thomas P. Gullotta, William Walton Stoops, Carl G. Leukefeld 251.
  • 2010From: CRCnetBASE
    edited by Cynthia M. Kuhn, George F. Koob.
    Advances in animal models of relapse for addiction research / Friedbert Weiss -- Application of chronic extracellular recording method to studies of cocaine self-administration : method and progress / Laura L. Peoples, Alexai V. Kravitz, and Karine Guillem -- Neurochemistry of addiction : monitoring essential neurotransmitters of addiction / Stefan G. Sandberg and Paul A. Garris -- Alcohol craving and relapse prediction : imaging studies / Andreas Heinz ... [et al.] -- Integrating behavioral and molecular approaches in mouse : self-administration studies / Danielle L. Graham and David W. Self -- Neuroeconomics : implications for understanding the neurobiology of addiction / Michael L. Platt ... [et al.].
  • 2011From: Springer
    Samir Zakhari, Vasilis Vasiliou, Q. Max Guo, editors.
    The World Health Organization has identified chronic alcohol consumption as one of the top ten risk factors for worldwide burden of disease. The International Agency for Research on Cancer has identified alcohol as carcinogenic to humans, including cancers of the upper aerodigestive tract, colon, liver and breast. Alcohol{u2019}s actions may be direct e.g. effects on retinoic acid and one-carbon metabolism, or indirect, through metabolites such as acetaldehyde and reactive oxygen species or through various signaling pathways that influence cell cycle and apoptosis that may contribute to carcinogenesis. This volume reviews the state of the art in alcohol-related cancer research in ten chapters.
  • 2012From: Wiley
    Iosief Abraha, Cristina Cusi.
    Part 1. Alcohol. Psychosocial interventions -- Effectiveness of brief alcohol interventions in primary care populations -- Brief interventions for heavy alcohol users admitted to general hospital wards -- Alcoholics Anonymous and other 12-step programmes for alcohol dependence -- Mentoring adolescents to prevent substance use disorders -- Universal school-based prevention programmes for alcohol misuse in young people -- Universal multicomponent prevention programmes for alcohol misuse in young people -- Universal family-based prevention programmes for alcohol misuse in young people -- Social norms interventions to reduce alcohol misuse in university or college students -- Psychosocial interventions for women enrolled in alcohol treatment during pregnancy -- Pharmacological interventions -- Benzodiazepines for alcohol withdrawal -- Anticonvulsants for alcohol withdrawal -- Acamprosate for alcohol dependence -- Baclofen for alcohol withdrawal -- Gamma-hydroxybutyrate for treatment of alcohol withdrawal and prevention of relapse -- Psychotropic analgesic nitrous oxide for alcohol withdrawal -- Efficacy and safety of pharmacological interventions for the treatment of alcohol withdrawal -- Opioid antagonists for alcohol dependence -- Pharmacologic interventions for pregnant women enrolled in alcohol treatment. Part 2. Drugs. Psychosocial interventions -- School-based prevention for illicit substance use disorders -- Interventions for prevention of substance use disorders by young people delivered in non-school settings -- Case management for persons with substance use disorders -- Motivational interviewing for substance use disorders -- Therapeutic communities for substance use disorders -- Interventions for drug-using offenders in the courts, secure estabishments and the community -- Psychosocial interventions for pregnant women in outpatient illicit drug treatment programmes compared to other interventions -- Cocaine dependence -- Psychosocial interventions for cocaine and psychostimulant amphetamine related disorders -- Antidepressants for cocaine dependence -- Antipsychotic medications for cocaine dependence -- Anticonvulsants for cocaine dependence -- Dopamine agonists for cocaine dependence -- Disulfiram for the treatment of cocaine dependence -- Efficacy of psychostimulant drugs for cocaine dependence -- Auricular acupuncture for cocaine dependence -- Psychosocial treatment for opiate dependence -- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification -- Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence -- Alpha2-adrenergic agonists for the management of opioid withdrawal -- Buprenorphine for the management of opioid withdrawal -- Psychosocial treatment for opiate dependence -- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification -- Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence -- Alpha2-adrenergic agonists for the management of opioid withdrawal -- Buprenorphine for the management of opioid withdrawal -- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence -- Methadone at tapered doses for the management of opioid withdrawal -- Methadone maintenance at different dosages for opioid dependence -- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence -- Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal -- Opioid antagonists with minimal sedation for opioid withdrawal -- Oral naltrexone maintenance treatment for opioid dependence -- Sustained-release naltrexone for opioid dependence -- Heroin maintenance for chronic heroin-dependent individuals -- LAAM maintainance verus methadone maintenance for heroin dependence -- Detoxification treatments for opiate-dependent adolescents -- Maintenance treatments for opiate-dependent adolescents -- Maintenance agonist treatment for opiate-dependent adolescents -- Maintenance agonist treatments for opiate-dependent pregnant women -- Pharmacological treatments for depression during opoid dependence -- Inpatient versus other setttings for detoxification for opiod dependence -- Psychotherapeutic interventions for cannabis use or dependence in outpatient settings -- Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings -- Treatment for amphetamine dependence -- Treatment for amphetamine withdrawal -- Treatment for amphetamine psychosis -- Treatment for methaqualone dependence in adults.
  • 2015From: ScienceDirect
    Amitava Dasgupta.
  • 2000From: NIAAA
    AOD thesaurusFrom: NIAAA
  • 2014From: ScienceDirect
    volume editors, Edith V. Sullivan and Adolf Pfefferbaum.
    "Alcohol is the most widely used drug in the world, yet alcoholism remains a serious addiction affecting nearly 20 million Americans. Our current understanding of alcohol's effect on brain structure and related functional damage is being revolutionized by genetic research, basic neuroscience, brain imaging science, and systematic study of cognitive, sensory, and motor abilities. Volume 125 of the Handbook of Clinical Neurology is a comprehensive, in-depth treatise of studies on alcohol and the brain covering the basic understanding of alcohol's effect on the central nervous system, the diagnosis and treatment of alcoholism, and prospect for recovery. The chapters within will be of interest to clinical neurologists, neuropsychologists, and researchers in all facets and levels of the neuroscience of alcohol and alcoholism"--Publisher's description.
  • 2011From: Springer
    Otto-Michael Lesch, Henriette Walter, Christian Wetschka, Michie Hesselbrock, Victor Hesselbrock.
  • edited by Eilish Gilvarry and Paul McArdle.
    Policy : the principles of service organization and practice / Paul McArdle and Eilish Gilvarry -- Determinants of substance misuse / Paul McArdle -- Drug use in young people : short-term effects and long-term harms / Dan Lubman, Yvonne Bonomo and Murat Yücel -- Young people, substances and harm / Mandy Abbott, Fariah Khan and Eilish Gilvarry -- Trends in substance use and abuse in young people / Cecilia A. Essau and Peter Wennberg -- Substance use and psychiatric comorbidity in children and adolescents / Michael Farrell -- The effectiveness of universal youth substance abuse prevention programmes / David R. Foxcroft, Debby Allen and Lindsey Coombes -- Prevention of substance abuse : targeted approaches / Paul McArdle -- Treatment : course and outcome / Eilish Gilvarry and Giles Hayden -- Legal and ethical issues in the treatment of children and young people / Sarah Woolrich -- Principles of assessment for adolescents with substance use disorders / Oscar G. Bukstein and Theresa Lutka-Fedor -- Assessment instruments and outcome measurement / Oscar G. Bukstein and Theresa Lutka-Fedor -- Biological markers (drugs) / Kim Wolff -- Assessement and management in the emergency department and the paediatric unit / Joan Robson -- Brief alcohol interventions in young people : evidence and applicability / Malathi Natarajan and Eileen Kaner -- Psychological interventions for young people with substance misuse disorders / Gillian Tober -- Empirical and clinical foundations of family-based interventions for adolescent substance abuse / Howard A. Liddle, Cynthia L. Rowe and Gayle A. Dakof -- Pharmacological treatment of adolescent substance use disorder / E. Jane Marshall and K.A.H. Mirza -- The role of primary care in management of substance use/abuse / Clare Gerada -- Integrated treatment of substance use disorders and co-occurring psychiatric disorders in adolescents / Robert D. Davies and Paula D. Riggs.
  • 2014From: Springer
    edited by David M. Guidot, Ashish J. Mehta.
    Alcohol Use Disorders and the Lung: A Clinical and Pathophysiological Approach is an excellent resource for clinicians who care for individuals affected by alcohol use disorders in diverse settings. Although alcohol abuse alone does not cause acute lung injury, it renders the lung susceptible to dysfunction in response to the inflammatory stresses of sepsis, trauma, and other clinical conditions recognized to cause acute lung injury. In parallel, these same pathophysiological effects of alcohol abuse significantly increase the risk of a wide range of serious lung infections. Many clinicians involved in the primary treatment of alcohol use disorders, such as addiction psychiatrists, will find this text of interest as it will expand their understanding of the health consequences of alcohol use disorders. In parallel, clinicians who specialize in pulmonary and/or critical care medicine will have a unique resource that provides a comprehensive review of the pathophysiology of alcohol-related lung disorders and insights into evolving therapeutic options in these vulnerable individuals. Alcohol Use Disorders and the Lung: A Clinical and Pathophysiological Approach fills a gap in the literature and presents the evolving clinical research that may soon lead to novel therapies that can improve lung health in individuals with alcohol use disorders and co-existing conditions such as HIV infection.
  • 2015From: PsychiatryOnline
    edited by Marc Galanter, M.D., Herbert D. Kleber, M.D., Kathleen T. Brady, M.D., Ph.D..
    Section I. The basis of addictive disorders -- Neurobiology of addiction -- Genetics of addiction -- Epidemiology of addiction -- Cross-cultural aspects of addiction -- Section II. The nature of treatment -- Science in the treatment of substance abuse -- Assessment of the patient -- Screening and brief intervention -- Patient placement criteria -- "Recovery" in chronic care disease management -- Section III. Specific drugs of abuse -- Neurobiology of alcohol use disorder -- Treatment of alcohol intoxication and alcohol withdrawal -- Neurobiology of stimulants -- Clinical management: cocaine -- Clinical management: methamphetamine -- Hallucinogens and club drugs -- Tobacco use disorder -- Benzodiazepines and other sedatives and hypnotics -- Treatment of anabolic-androgenic steroid-related disorders -- Neurobiology of opiates and opioids -- Opioid detoxification -- Methadone and buprenorphine maintenance -- Opioid antagonists -- Neurobiology of marijuana -- Treatment of cannabis use disorder -- Section IV. Treatment modalities -- Psychodynamic psychotherapy -- Cognitive-behavioral therapies -- Motivational enhancement -- Twelve-step facilitation -- Contingency management -- Network therapy -- Group therapy -- Family therapy -- Section V. Rehabilitation settings -- Inpatient treatment -- Therapeutic communities -- Community-based treatment -- History of alcoholics anonymous and the experiences of patients -- Psychological mechanisms in alcoholics anonymous -- Outcomes research on twelve-step programs -- Section VI. Special populations -- Women and addiction -- Perinatal substance use disorders -- Adolescent substance use disorders: epidemiology, neurobiology, and screening -- Adolescent substance use disorders: transition to substance abuse, prevention, and treatment -- Psychiatric consultation in pain and addiction -- Prevention of prescription drug abuse -- HIV/AIDS and hepatitis C -- Substance use disorders among physicians -- Substance use issues among gay, lesbian, bisexual, and transgender people -- Minorities -- Section VII. Special topics -- Testing to identify recent drug use -- Medical education on addiction -- Prevention of substance abuse -- Forensic addiction psychiatry -- Substance abuse and mental illness -- Substance-related and addictive disorders.
  • edited by Marc Galanter, Herbert D. Kleber.
    PrintStatus: Not Checked OutLane Catalog Record
    Part 1 : The basis of addictive disorders -- Neurobiology of addiction / George F. Koob -- Genetics of addiction / Joel Gelernter, Henry R. Kranzler -- Epidemiology of addiction / Judith S. Brook, Kerstin Pahl, Elizabeth Rubenstone -- Cross-cultural aspects of addiction / Nady el-Guebaly -- Part 2 : The nature of treatment -- Assessment of the patient / Shelly F. Greenfield, Grace Hennessy -- Patient placement criteria / David Mee-Lee, David R. Gastfriend -- Evolution in addiction treatment concepts and methods / A. Thomas McLellan -- Part 3 : Specific drugs of abuse -- Alcohol -- Neurobiology of alcohol / Clifford M. Knapp, Domenic A. Ciraulo, Henry R. Kranzler -- Clinical management of alcohol abuse and dependence / Hugh Myrick, Tara Wright -- Stimulants -- Neurobiology of stimulants / Margaret Haney -- Clinical management : cocaine / Thomas R. Kosten, Mehmet Sofuoglu, Tracie J. Gardner -- Clinical management : methamphetamine / Richard A. Rawson, Walter Ling -- Hallucinogens and club drugs -- Neurobiology of hallucinogens / Richard A. Glennon -- Hallucinogens and club drugs / Michael F. Weaver, Sidney H. Schnoll -- Other substances -- Nicotine and tobacco / Tony P. George, Andrea H. Weinberger -- Benzodiazepines and other sedatives and hypnotics / Adam Bisaga -- Treatment of anabolic-androgenic steroid-related disorders / Harrison G. Pope, Jr., Kirk J. Brower -- Opioids -- Neurobiology of opiates and opioids / Mary Jeanne Kreek -- Detoxification of opioids / Soteri Polydorou, Herbert D. Kleber -- Opioid maintenance treatment / Richard S. Schottenfeld -- Buprenorphine maintenance / Eric C. Strain, Michelle R. Lofwall -- Antagonists of opioids / Charles O'Brien, Kyle M. Kampman -- Part 4 : Treatment modalities -- Psychodynamics / Hallie A. Lightdale, Avram H. Mack, Richard J. Frances -- Cognitive-behavioral therapies / Kathleen M. Carroll -- Motivational enhancement / Carlo C. DiClemente, Miranda Garay, Leigh Gemmell -- Twelve-step facilitation / Richard K. Ries, Marc Galanter, J. Scott Tonigan -- Contingency management / Stephen T. Higgins, Kenneth Silverman -- Network therapy / Marc Galanter -- Group therapy / David W. Brook -- Family therapy / Timothy J. O'Farrell, William Fals-Stewart -- Part 5 : Rehabilitation settings -- Inpatient treatment / Roger D. Weiss, Jennifer Sharpe Potter, Rocco A. Iannucci -- Therapeutic communities / George De Leon -- Community-based treatment / Jonathan I. Ritvo, Harvey L. Causey III -- Alcoholics anonymous and other 12-step programs -- Psychological mechanisms in alcoholics anonymous / J. Scott Tonigan, Gerard J. Connors -- The history of alcoholics anonymous and the experiences of patients / Edgar P. Nace -- Outcome research on 12-step and other self-help programs / Rudolf H. Moos, Christine Timko -- Part 6 : Special populations -- Adolescent substance abuse / Yifrah Kaminer -- The mentally ill substance abuser / Stephen Ross -- Women and addiction / Kathleen T. Brady, Sudie E. Back -- Perinatal substance abuse / Loretta P. Finnegan, Stephen R. Kandall -- HIV/AIDS and hepatitis C / Steven L. Batki, Kalpana I. Nathan -- Prescription drug abuse / Wilson M. Compton, Richard Denisco -- Substance use disorders among physicians / J. Wesley Boyd, John R. Knight -- Gay men and lesbians / Robert Paul Cabaj -- Minorities / Joseph Westermeyer, Daniel Dickerson -- Part 7 : Special topics -- Testing to identify recent drug use / Robert L. DuPont, Carl M. Selavka -- Medical education / Erik W. Gunderson, Frances R. Levin, Petros Levounis -- Prevention of substance abuse / Richard R. Clayton, Melissa J.H. Segress, Crystal A. Caudill -- Forensic addiction psychiatry / Avram H. Mack, Monica Barros.
  • 1998From: Google Books
    Office of Applied Studies.
    Also available: Print – 1998
  • Jin Woo Im.
    Using U.S. Department of Veterans Affairs (VA) records, this dissertation explores the staffing mix in substance use disorder treatment programs (SUDTPs) and the effectiveness of the current clinical practice guideline in reducing suicide risk associated with opioid therapy. The VA treats a large number of Veterans diagnosed with substance use disorders (SUDs) in four types of specialized SUDTPs at an annual cost of more than $350 million. The staffing mixes were not significantly different from 2001 to 2003, the years under review. However, given differences in treatment focus and provided services, the four types of SUDTPs may require different staffing mixes. We demonstrate how cost-effective staffing mixes for each type of VA SUDTP can be defined empirically. We derive prediction functions for benefits and costs based on patients' treatment outcomes at VA SUDTPs nationally from 2001 to 2003, and use them to formulate optimization problems to determine recommended staffing mixes that maximize net benefits per patient for four types of SUDTPs while conforming to limits of current practice. Compared to the actual staffing mixes in 2001-2003, the recommended staffing mixes would lower treatment costs while improving patient outcomes. We also introduce an approach to building a decision support system for staffing each type of SUDTP reflecting the dynamics of effectiveness and costs associated with the staffing changes. Compared to the actual staffing mixes, the staffing mixes suggested by the staffing decision support system are expected to treat significantly more Veteran patients under the existing staffing budget while improving patient outcomes. We also examine associations between adherence to guideline recommendations and the risk of suicide attempt based on Veterans Health Administration (VHA) records. Opioid therapy is often provided to reduce chronic pain in at-risk patients. Unfortunately, available opioid medications have been also used as a means for attempting suicide. In 2010, the VHA and the Department of Defense released a jointly developed clinical practice guideline (CPG) to reduce the risk of adverse events such as suicide attempt in patients prescribed opioids, primarily based on expert consensus. We conduct multivariate mixed-effects logistic regression analyses to define the associations between facility-level CPG adherence rates and risk of suicide attempt while controlling for the associations between individual-level delivery of CPG-based services and the risk of suicide attempt. Major findings include the following: suicide attempts were negatively associated with facility-level adherence rates for both consistent urine drug screenings and follow-up appointments, and were positively associated with facility-level risky sedative co-prescription rates.
  • 2011From: Springer Protocols
    edited by Mary C. Olmstead.
    Intracranial self-stimulation / Styliani Vlachou and Athina Markou -- Stimulant self-administration / Leigh V. Panlilio -- Opiate self-administration / Francesco Leri -- Nicotine self-administration / Robert E. Sorge and Paul B.S. Clarke -- Alcohol self-administration / Friedbert Weiss -- Place conditioning / Christopher L. Cunningham, Peter A. Groblewski, and Charlene M. Voorhees -- Sensitization / Jessica A. Loweth and Paul Vezina -- Animal models of eating disorders / Stephanie D. Hancock and Mary C. Olmstead -- Acquisition of drug self-administration / Marilyn E. Carroll and Richard A. Meisch -- Escalation of drug use / Serge H. Ahmed -- Environmental modulation of drug taking / Aldo Badiani ... [et al.] -- Craving / Jeffrey W. Grimm -- Habit formation and compulsion / David Belin ... [et al.] -- Impulsivity / Andrea Bari, Trevor W. Robbins, and Jeffrey W. Dalley -- Binge drug taking / Herbert E. Covington, III and Klaus A. Miczek -- Withdrawal / Alasdair M. Barr, Heidi N. Boyda, and Ric M. Procyshyn -- Relapse / Suzanne Erb and Franca Placenza.
  • 2008From: Springer
    Sherry H. Stewart, Patricia J. Conrod editors.
    Theoretical issues -- Epidemiological perspectives on co-occurring anxiety disorder and substance use disorder -- The neurobiology of anxiety: potential for co-morbidity of anxiety and substance use disorders -- Research findings -- Posttraumatic stress disorder and substance use disorder: neuroimaging, neuroendocrine, and psychophysiological findings -- Co-morbidity of social phobia and alcohol use disorders: a review of psychopathology research findings -- Panic spectrum disorders and substance use -- Treatment strategies -- Treatment of co-morbid obsessive-compulsive disorder and substance use disorders -- Treatment for co-morbid posttraumatic stress disorder and substance use disorders -- Treatment of co-occurring alcoholism and social anxiety disorder -- Treating co-morbid panic disorder and substance use disorder -- Cognitive- behavioral treatment of co-morbid panic psychopathology and tobacco use and dependence -- Personality-based approaches to treatment of co-morbid anxiety and substance use disorder -- Medical management of co-morbid anxiety and substance use disorder -- Integration and conclusions -- Anxiety disorder and substance use disorder co-morbidity: common themes and future directions.
  • senior editor, Richard K. Ries ; associate editors, David A. Fiellin, Shannon C. Miller, Richard Saitz
    PrintStatus: Not Checked OutLane Catalog Record
    Section 1. Basic Science and Core Concepts : -- 1. Drug Addiction: The Neurobiology of Behavior Gone Awry -- 2. The Epidemiology of Substance Use Disorders -- 3. The Anatomy of Addiction -- 4. From Neurobiology to Treatment: Progress Against Addiction -- 5. Understanding "Behavioral Addictions": Insights from Research -- -- Section 2. Pharmacology : -- 6. Pharmacokinetic and Pharmacodynamic Principles -- 7. The Pharmacology of Alcohol -- 8. The Pharmacology of Nonalcohol Sedative Hypnotics -- 9. The Pharmacology of Opioids -- 10. The Pharmacology of Cocaine, Amphetamines, and Other Stimulants -- 11. The Pharmacology of Caffeine -- 12. The Pharmacology of Nicotine and Tobacco -- 13. The Pharmacology of Marijuana -- 14. The Pharmacology of Hallucinogens -- 15. The Pharmacology of Dissociatives -- 16. The Pharmacology of Inhalants -- 17. The Pharmacology of Anabolic-Androgenic Steroids -- -- Section 3. Diagnosis, Assessment, and Early Intervention : -- 18. Screening and Brief Intervention -- 19. Laboratory Diagnosis -- 20. Assessment -- 21. Environmental Approaches to Prevention: A Community-Based Perspective -- -- Section 4. Overview of Addiction Treatment : -- 22. Addiction Medicine in America: Its Birth and Early History (1750-1935) with a Modern Postscript -- 23. Treatment of Heavy Drinking and Alcohol Use Disorder -- 24. The Treatment of Drug Addiction: An Overview -- 25. Moving Toward Integrated Care for Substance Use Disorders: Lessons from History and the Rest of Health Care -- 26. Effects of Treatment Setting, Duration, and Amount on Patient Outcomes -- 27. The ASAM Criteria and Matching Patients to Treatment -- 28. Linking Addiction Treatment with Other Medical and Psychiatric Treatment Systems -- 29. Alternative Therapies for Alcohol and Drug Addiction -- 30. The Harm Reduction Approach to Prevention and Treatment -- 31. Quality Improvement for Addiction Treatment -- 32. Nursing Roles in Addressing Addiction -- 33. International Perspectives on Addiction Management -- -- Section 5. Special Issues in Addiction : -- 34. Nonmedical Use, Misuse, and Abuse of Prescription Medications -- 35. Special Issues in Treatment: Women -- 36. Treatment of Older Adults -- 37. Cultural Issues in Addiction Medicine -- 38. College Student Drinking -- 39. Pathologic Gambling: Clinical -- 40. Sexual Addiction -- 41. Physician Health Programs and Addiction among Physicians -- -- Section 6. Management of Intoxication and Withdrawal : -- 42. Management of Intoxication and -- 43. Management of Alcohol Intoxication and Withdrawal -- 44. Management of Sedative-Hypnotic Intoxication and Withdrawal -- 45. Management of Opioid Intoxication and Withdrawal -- 46. Management of Stimulant, Hallucinogen, Marijuana, Phencyclidine, and Club Drug Intoxication and Withdrawal -- -- Section 7. Pharmacologic Interventions : -- 47. Medications for Use in Alcohol -- 48. Pharmacologic Intervention for Sedative-Hypnotic Addiction -- 49. Pharmacologic Interventions for Opioid Dependence -- 50. Opioid Maintenance Treatment -- 51. Special Issues in Office-Based Opioid Treatment -- 52. Pharmacologic Interventions for Cocaine, Methamphetamine, and Other Stimulant Addiction -- 53. Pharmacologic Interventions for Tobacco Dependence -- 54. Pharmacologic Interventions for Other Drug and Multiple Drug Addictions -- -- Section 8. Behavioral Interventions : -- 55. Enhancing Motivation to Change -- 56. Group Therapies -- 57. Individual Treatment -- 58. Contingency Management and the Community Reinforcement Approach -- 59. Behavioral Interventions in Smoking Cessation -- 60. Network Therapy -- 61. Therapeutic Communities -- 62. Aversion Therapies -- 63. Family Involvement in Addiction, Treatment, and Recovery -- 64. Twelve-Step Facilitation Approaches -- 65. Microprocessor Abuse and Internet Addiction -- 66. Relapse Prevention: Clinical Models and Intervention Strategies -- 67. Medical Management Techniques and Collaborative Care: Integrating Behavioral with Pharmacologic Interventions in Addiction Treatment -- 68. Conceptual and Treatment Issues in "Behavioral Addictions" -- -- Section 9. Mutual Help, Twelve Step, and Other Recovery Programs : -- 69. Twelve-Step Programs in Addiction Recovery -- 70. Recent Research into Twelve-Step Programs -- 71. Spirituality in the Recovery Process -- -- Section 10. Medical Disorders and Complications of Addiction : -- 72. Medical and Surgical Complications of Addiction -- 73. Cardiovascular Consequences of Alcohol and Other Drug Use -- 74. Liver Disorders Related to Alcohol and Other Drug Use -- 75. Renal and Metabolic Disorders Related to Alcohol and Other Drug Use -- 76. Gastrointestinal Disorders Related to Alcohol and Other Drug Use -- 77. Respiratory Tract Disorders Related to Alcohol and Other Drug Use -- 78. Neurologic Disorders Related to Alcohol and Other Drug Use -- 79. Human Immunodeficiency Virus, Tuberculosis, and Other Infectious Diseases Related to Alcohol and Other Drug Use -- 80. Sleep Disorders Related to Alcohol and Other Drug Use -- 81. Traumatic Injuries Related to Alcohol and Other Drug Use: Epidemiology, Screening, and Prevention -- 82. Endocrine and Reproductive Disorders Related to Alcohol and Other Drug Use -- 83. Alcohol and Other Drug Use during Pregnancy: Management of the Mother and Child -- 84. Surgical Interventions in the Alcohol- or Drug-Using Patient -- -- Section 11. Co-Occurring Addiction and Psychiatric Disorders : -- 85. Substance-Induced Mental Disorders -- 86. Co-Occurring Addictive and Mood Disorders -- 87. Co-Occurring Addiction and Anxiety Disorders -- 88. Co-Occurring Addiction and Psychotic Disorders -- 89. Co-Occurring Addictive Disorder and Attention Deficit Hyperactivity Disorder -- 90. Co-Occurring Personality Disorders and Addiction -- 91. Posttraumatic Stress Disorder and Substance Use Disorder Comorbidity -- 92. Co-Occurring Addiction and Eating Disorders -- -- Section 12. Pain and Addiction : -- 93. The Pathophysiology of Chronic Pain and Clinical Interfaces with Addiction -- 94. Psychological Issues in the Management of Pain -- 95. Rehabilitation Approaches to Pain Management -- 96. Nonopioid Pharmacotherapy of Pain -- 97. Opioid Therapy of Pain -- 98. Comorbid Pain and Addiction -- 99. Legal and Regulatory Considerations in Opioid Prescribing -- -- Section 13. Children and Adolescents : -- 100. Epidemiology of Adolescent Substance Use -- 101. Preventing Substance Use among Children and Adolescents -- 102. Neurobiology of Addiction from a Developmental Perspective -- 103. Screening and Brief Intervention for Adolescents -- 104. Assessing Adolescent Substance Use -- 105. Placement Criteria and Strategies for Adolescent Treatment Matching -- 106. Adolescent Treatment and Relapse Prevention -- 107. Pharmacotherapy for Adolescents with Substance Use Disorders -- 108. Co-Occurring Psychiatric Disorders in Adolescents -- -- Section 14. Ethical, Legal, and Liability Issues in Addiction Practice : -- 109. Ethical Issues in Addiction Practice -- 110. Consent and Confidentiality Issues in Addiction Practice -- 111. Clinical, Ethical, and Legal Considerations in Prescribing Drugs with Abuse Potential -- 112. The Science and Clinical Uses of Drug Testing -- 113. Drug Treatment Courts and the Treatment of Persons in the Criminal Justice System -- 114. Preventing and Treating Substance Use Disorders in Military Personnel.
  • 2010From: Springer
    Amitava Dasgupta.
  • 2013From: Springer
    Wolfgang H. Sommer, Rainer Spanagel, editors.
    Part I. Mechanistic Aspects Underlying Alcoholism -- Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit Disorder / George F. Koob -- Synaptic Effects Induced by Alcohol / David M. Lovinger and Marisa Roberto -- Signaling Pathways Mediating Alcohol Effects / Dorit Ron and Robert O. Messing -- Neurocircuitry Involved in the Development of Alcohol Addiction: The Dopamine System and its Access Points / Bo Söderpalm and Mia Ericson -- What is in that Drink: The Biological Actions of Ethanol, Acetaldehyde, and Salsolinol / Gerald A. Deehan Jr., Mark S. Brodie and Zachary A. Rodd -- Part II. Genetics -- Modeling the Diagnostic Criteria for Alcohol Dependence with Genetic Animal Models / John C. Crabbe, Kenneth S. Kendler and Robert J. Hitzemann -- Non-Human Primate Models of Alcohol-Related Phenotypes: The Influence of Genetic and Environmental Factors / Christina S. Barr -- Genetically Selected Alcohol Preferring Rats to Model Human -- Alcoholism / Roberto Ciccocioppo -- Advanced Transgenic Approaches to Understand Alcohol-Related Phenotypes in Animals / Ainhoa Bilbao -- Part III. Clinical Phenotypes and Preclinical Models Thereof Modeling Alcohol Self-Administration in the Human Laboratory / Ulrich S. Zimmermann, Sean O'Connor and Vijay A. Ramchandani -- Animal Models of Excessive Alcohol Consumption in Rodents / Howard C. Becker -- Modeling Relapse Situations in the Human Laboratory / Rajita Sinha -- Modeling Relapse in Animals / Rémi Martin-Fardon and Friedbert Weiss -- Invertebrate Models of Alcoholism / Henrike Scholz and Julie A. Mustard -- Part IV. Novel Insights from Brain Imaging The Dopamine System in Mediating Alcohol Effects in Humans / K. Charlet, A. Beck and A. Heinz -- Stimulant and Sedative Effects of Alcohol / Reuben A. Hendler, Vijay A. Ramchandani, Jodi Gilman and Daniel W. Hommer -- Chronic Alcohol Consumption, Abstinence and Relapse: Brain Proton Magnetic Resonance Spectroscopy Studies in Animals and Humans / Dieter J. Meyerhoff, Timothy C. Durazzo and Gabriele Ende -- Part V. Translational Aspects and Medication Development -- Translational Approaches to Medication Development / Selena Bartlett and Markus Heilig -- New Pharmacological Treatment Strategies for Relapse Prevention / Rainer Spanagel and Valentina Vengeliene -- The Challenge of Studying Parallel Behaviors in Humans and Animal Models / David N. Stephens, Hans S. Crombag and Theodora Duka -- A Translational Approach to Novel Medication Development for Protracted Abstinence / Barbara J. Mason and Amanda E. Higley -- New Approaches to Addiction Treatment Based on Learning and Memory / Falk Kiefer and Christina Dinter -- Adolescent Substance Misuse: Neurobiology and Evidence-Based Interventions / Nicola C. Newton, Maeve O'Leary-Barrett and Patricia J. Conrod -- Deep Brain Stimulation as a Therapy for Alcohol Addiction / Thomas F. Münte, Hans-Jochen Heinze and Veerle Visser-Vandewalle.
  • 2010From: Springer
    David W. Self, Julie K. Staley, editors.
  • 2016From: Springer
    Ivan D. Montoya, editor.
    Introduction -- PART I: Vaccines: Introduction -- Nicotine -- Cocaine -- Heroin -- Metamphetamine -- PART II: Monoclonal antibodies: Introduction -- Cocaine -- Metamphetamine -- PCP -- PART III: Enzymes: Introduction -- Butyrylcholinesterase -- Cocaine Esterase -- PART IV: New strategies to optimize the development of biologics: Adenovirus based vaccines -- Nanotechnology based vaccines -- Protein Nanoparticles -- DNA Scaffolded Vaccines -- Single Hapten Conjugate Therapeutic Vaccine -- Vaccine Adjuvants -- Laser Adjuvant -- Peptide Conjugates & Cytokine Adjuvants -- T. brucei: A Platform for Immunization -- Vaccines for SUDs and HIV infection -- New Monoclonal Antibodies -- Protein Engineered for Controlled Duration of Action -- PART V: Ethical aspects of biologics to treat SUDs.
  • edited by Cynthia M.A. Geppert and Laura Weiss Roberts.
    PrintStatus: Not Checked OutLane Catalog Record
    Ethical foundations of substance abuse treatment / Cynthia M.A. Geppert, Laura Weiss Roberts -- The therapeutic relationship in substance abuse treatment / Jennifer Knapp Manuel, Alyssa A. Forcehimes -- The ethics of harm reduction / William R. Miller -- Ethical issues in the treatment of persons with co-occurring disorders / Christie A. Cline, Kenneth Minkoff -- Cultural and spiritual dimensions of addiction treatment / Kamilla L. Venner, Michael P. Bogenschutz -- Forensic issues in the treatment of addictions / Joseph B. Layde -- Ethical issues in the treatment of women with substance abuse / Diane T. Castillo, Ann Waldorf -- Ethical aspects of the treatment of substance abuse in children and adolescents / Jerald Belitz -- Ethical dilemmas in treating chronic pain in the context of addiction / Joanna G. Katzman, Cynthia M.A. Geppert.
  • 2006From: CRCnetBASE
    Steven B. Karch.
  • 2016From: Wiley
    Hermine L. Graham, Alex Copello, Max Birchwood, Emma Griffith.
    Brief Integrated Motivational Intervention provides clinicians and specialist practitioners with a brief, evidence-based treatment approach for motivating clients, who have comorbid mental health and alcohol and drug misuse. -Combines CBT, motivational interviewing, and the authors' own cognitive- behavioural integrated treatment (C-BIT) to engage clients in meaningful dialogue for change -Utilizes the short 'window of opportunity' when clients are admitted to psychiatric hospital or have recently relapsed, and helps clinicians to maximize the potential of this 'teachable moment' -Helpful tools such as session-specific content, illustrative case material and easy-to-use worksheets facilitate implementation of the approach across a range of settings including inpatient, community, and residential -Developed by an expert team with many years of experience in both research and practice in the fields of psychosis and addiction.
  • 2013From: CRCnetBASE
    Alan Rodgman and Thomas A. Perfetti.
    Ch. 1. Hydrocarbons -- ch. 2. Alcohols and phytosterols -- ch. 3. Aldehydes and ketones -- ch. 4. Carboxylic acids -- ch. 5. Esters -- ch. 6. Lactones -- ch. 7. Anhydrides -- ch. 8. Carbohydrates and their derivatives -- ch. 9. Phenols and quinones -- ch. 10. Ethers -- ch. 11. Nitriles -- ch. 12. Acyclic amines -- ch. 13. Amides -- ch. 14. Imides -- ch. 15. N-nitrosamines -- ch. 16. Nitroalkanes, nitroarenes, and nitrophenols -- ch. 17. Nitrogen heterocyclic components -- ch. 18. Miscellaneous components -- ch. 19. Fixed and variable gases -- ch. 20. Metallic and nonmetallic elements, isotopes, ions, and salts -- ch. 21. Pesticides and growth regulators -- ch. 22. Genes, nucleotides, and enzymes -- ch. 23. Hoffmann analytes -- ch. 24. Tobacco and/or tobacco smoke components used as tobacco ingredients -- ch. 25. Pyrolysis -- ch. 26. Carcinogens, tumorigens, and mutagens vs. anticarcinogens, inhibitors, and antimutagens -- ch. 27. Free radicals -- ch. 28. Summary.
  • 2011From: Karger
    volume editors, M.R. Clark, G.J. Treisman.
    Patients with chronic pain understandably seek relief from their distress and discomfort, but many medications that alleviate pain are potentially addictive, and most chronic pain conditions only have a temporary response to opiate analgesic drugs. This volume reviews the fundamental topics that underlie the complex relationships of this controversial domain. The authors review behavioral models and practical methods for understanding and treating chronic pain and addiction including methods to formulate patients with complex comorbidity and screen patients with chronic pain for addictive liability. Finally, the authors describe the current findings from clinical and basic science that illuminate the role of opiates, cannabinoids and ketamine in the treatment of chronic pain. Up to date and comprehensive, this book is relevant to all professionals engaged in the care of patients with chronic pain or addiction and all others interested in these contemporary issues, particularly non-clinicians seeking clarity in the controversy over the best approach to patients with chronic pain.
  • 2006From: Springer
    Barry B. Halliwell, Henrik E. Poulsen, editors.
  • David Sheff.
    PrintStatus: Not Checked OutLane Catalog Record
    Author David Sheff offers a new paradigm for dealing with addiction based on cutting-edge research and stories of his own and other families' struggles with--and triumphs over--drug abuse. "Addiction is a preventable, treatable disease, not a moral failing. As with other illnesses, the approaches most likely to work are based on science -- not on faith, tradition, contrition, or wishful thinking. These facts are the foundation of Clean, a myth-shattering look at drug abuse by the author of Beautiful Boy. Based on the latest research in psychology, neuroscience, and medicine, Clean is a leap beyond the traditional approaches to prevention and treatment of addiction and the mental illnesses that usually accompany it. The existing treatment system, including Twelve Step programs and rehabs, has helped some, but it has failed to help many more, and David Sheff explains why. He spent time with scores of scientists, doctors, counselors, and addicts and their families to learn how addiction works and what can effectively treat it. Clean offers clear, cogent counsel for parents and others who want to prevent drug problems and for addicts and their loved ones no matter what stage of the illness they're in. But it is also a book for all of us -- a powerful rethinking of the greatest public health challenge of our time."-- Book jacket.
  • 2015From: Springer
    Geert Dom, Franz Moggi, editors.
    This book provides a comprehensive, state of the art overview covering both the diagnosis and the treatment of dual disorders ? joint psychiatric and substance use disorders ? in a way that is highly relevant to clinical work and the organization of care systems. It is designed to meet the real need for a European perspective on dual disorders, taking into account the realities of European treatment organization. All chapters have been written by European authors on the basis of existing European treatment programs or guidelines and European research. Dual disorders are increasingly encountered by health professionals working in mental health and addiction care, and they represent a formidable challenge for caregivers, care organizations, and society as a whole. During the past decade, various approaches and programs have been designed to challenge the traditional gap between addiction treatment and mental health care. The overwhelming majority of the programs, however, have emanated from the United States. Given the vast differences between the European and U.S. health contexts, it can be questioned whether these American-oriented treatment programs are of value in European countries. Co-occurring Addictive and Psychiatric Disorders ? A Practice-Based Handbook from a European Perspective therefore represents a timely and much-needed addition to literature on the subject.
  • 2013From: ScienceDirect
    editor-in-chief, Peter M. Miller.
    The volume presents current material on the key neurobiological and genetic elements in an individual's susceptibility to drug dependence as well as the processes by which some individuals proceed from casual drug use to drug dependence. Chapters describe and explain the neurobiological mechanisms of drug use and drug addiction. The development and use of animal models to study neurochemical, molecular and cellular brain mechanisms are described and illustrated. Other chapters discuss the effects of drug use on memory, decision-making, and the developing brain (especially in adolescents).
  • 2013From: ScienceDirect
    editor-in-chief, Peter M. Miller.
    Volume 3, Intervention for Addictions, provides chapters on psychosocial treatments, pharmacological treatments, provision of health care to addicted individuals, prevention, and public policy issues. Basically, this volume contains the practical application of the information in Volumes 1 and 2. Overall, this volume provides a detailed picture of the myriad of science-based interventions available for the treatment of addiction. With the expanding growth of neurobiological research newer and more effective pharmacological treatments should be available on the near horizon.
  • 2005From: ScienceDirect
    edited by Victor R. Preedy and Ronald Ross Watson.
    Part I. General aspects of alcohol toxicity, consumption, and disease -- Part II. Damage/disease: -- General aspects of pathology -- Organ damage -- Cells, pathways, interactions, processes -- Part III. Selective methods used in alcohol research -- Index.
    Also available: Print – v. 1-3, 2005.
  • 2012From: Springer
    Boris Gutkin, Serge H. Ahmed, editors.
    Pt. 1. Pharmacological-based models of addiction -- pt. 2. Neurocomputational models of addiction -- pt. 3. Economic-based models of addiction.
  • Center on Addiction and Substance Abuse at Columbia University.
    PrintStatus: Not Checked OutLane Catalog Record
    Report 1. Medicaid hospital costs -- Report 2. Medicare hospital costs.
  • Office of Applied Studies; [compiled by] Tara N. Townsend ... [et al.].
  • 2007From: CRCnetBASE
    editor-in-chief, Steven B. Karch.
    Criminalistics: introduction to controlled substances / Joseph P. Bono -- Pathology of drug abuse / edited by Charles V. Wetli -- Pharmacokinetics: drug absorption, distribution, and elimination / Amanda J. Jenkins -- Pharmacodynamics / edited by Stephen J. Heishman -- Alcohol / edited by Alan Wayne Jones -- Neurochemistry of drug abuse / edited by Julie K. Staley and Kelly P. Cosgrove -- Addiction medicine / edited by Kim Wolff -- Medical complications of drug abuse / edited by Neal L. Benowitz -- Sports / edited by Marc D. Bollmann and Martial Saugy -- Workplace testing / edited by Yale H. Caplan and Marilyn A. Huestis -- Point of collection drug testing / edited by Dennis J. Crouch -- Post-mortem toxicology / edited by Henrik Druid -- Toxicogenetics / edited by Steven B. Karch -- Drug law -- Appendices.
  • edited by Jasbir M. Singh, Lyle Miller, Harbans Lal.
    PrintStatus: Not Checked OutLane Catalog Record
    v. 1. Experimental pharmacology -- v. 2. Clinical and socio-legal aspects -- v. 3. Neurobiology and influences on behaviour -- v. 4. New aspects of analytical and clinical toxicology.
  • 2008From: Springer
    edited by Rao S. Rapaka, Wolfgang Sadée.
  • 2006From: Springer
    Marc A. Schuckit.
    Depressants -- Alcoholism: an introduction -- Alcoholism: acute treatment -- Stimulants: amphetamines and cocaine -- Opioids and other analgesics -- Cannabinols -- Hallucinogens and related drugs -- Glues, inhalants and aeorsols -- Over-the-counter (OTC) drugs and some prescription drugs -- Xanthines (caffeine) and nicotine -- Multidrug abuse and dependence -- Emergency problems: a quick overview -- Rehabilitation.
  • Anna Lembke, MD.
    1. What is addiction, who's at risk, and how do people recover? -- 2. Prescription drugs as the new gateway to addiction -- 3. Pain is dangerous, difference is psychopathology : the role of illness narratives -- 4. Big Pharma joins Big Medicine : co-opting medical science to promote pill-taking -- 5. The drug-seeking patient : malingering versus the hijacked brain -- 6. The professional patient : illness as identity and a right to be compensated -- 7. The compassionate doctor, the narcissistic injury, and the primitive defense -- 8. Pill mills and the Toyota-ization of medicine -- 9. Addiction, the disease insurance companies still won't pay doctors to treat -- 10. Stopping the cycle of compulsive prescribing.
  • 2014From: Springer
    Timothy D. Brewerton, Amy Baker Dennis, editors.
    Eating disorders, addictions, and substance use disorders are each challenging in their own right, but they also commonly co-occur, causing major challenges for clinicians. Emerging research suggests that there are common substrates at the neuroanatomical, neurochemical, and psychological levels. While randomized controlled trials have revealed a number of effective psychotherapeutic and psychopharmacologic treatments for the individual conditions, little is known about integrative interventions for these comorbidities. This book presents cutting-edge research on the overlap of these complex disorders and reviews integrative assessment strategies and treatment approaches, including enhanced cognitive behavioral therapy, dialectical behavior therapy, abstinence approaches, motivational enhancement, mindfulness meditation, and pharmacotherapy. The issue of whether eating-disordered behaviors such as dieting, binge eating, and excessive exercise are merely other forms of addictive behavior is examined. The authors argue both for and against the concept of food addiction in research, clinical treatment, and public policy.
  • 2013From: ScienceDirect
    edited by Bertha Madras and Michael Kuhar.
    Drug use and abuse continues to thrive in contemporary society worldwide and the instance and damage caused by addiction increases along with availability. The Effects of Drug Abuse on the Human Nervous System presents objective, state-of-the-art information on the impact of drug abuse on the human nervous system, with each chapter offering a specific focus on nicotine, alcohol, marijuana, cocaine, methamphetamine, MDMA, sedative-hypnotics, and designer drugs. Other chapters provide a context for drug use, with overviews of use and consequences, epidemiology and risk factors, genetic.
  • 2013From: Wiley
    edited by Willm Mistral.
    Contributors -- About the editor -- Preface / Willm Mistral -- Changing perspectives on problematic drug use / Richard Velleman -- Formulating effective alcohol policy : not as simple as it sounds / Robin Davidson -- Binge drinking : consumption, consequences, causes and control / Willm Mistral -- A picture tells a thousand stories : young women, mobile technology and drinking narratives / Rebecca Brown -- Exploring emerging perspectives on gender and drug use / Karenza Moore and Fiona Measham -- Embracing children and families in substance misuse treatment / Lorna Templeton -- In their own right : developing confidential services for children and young people affected by parental alcohol and drug use / Louise Hill -- Screening for alcohol use disorders / Lesley Smith -- From comorbidity to multiple health behaviour change / Amanda Baker, Sarah Hiles, Louise Thornton, Amanda Searl, Peter Kelly and Frances Kay-Lambkin -- Counselling in intensive structured day treatment : the co-production of recovery / Tim Leighton -- Movements towards recovery / Willm Mistral and Stephen Wilkinson -- How current drug laws impede research and clinical treatments / David Nutt -- Index.
  • 2011From: WHO
    Introduction to the guidelines. Purpose, target and scope -- Background -- A dual obligation, a quadruple imperative -- Indispensability of controlled medicines in contemporary medical practices -- Safety of controlled medicines -- Current availability -- Impediments to availability, accessibility and affordability -- Why and how to work with this document? -- Guidelines for ensuring balance in national policies on controlled substances. Content of drug control legislation and policy -- Authorities and their role in the system -- Policy planning for availability and accessibility -- Healthcare professionals -- Estimates and statistics -- Procurement -- Other -- Country assessment checklist.
    Also available: Print – 2011
  • 2006From: NCI
    National Cancer Institute.
  • 2009From: ClinicalKey
    edited by Peter M. Miller.
    The addictions treatment field is currently undergoing a period of increased scrutiny, upheaval and change. The growing emphasis on treatment accountability and cost effectiveness is leading to major changes in standards of care. Inconsistent practices based solely on clinical intuition rather than hard scientific evidence of treatment efficacy are rapidly becoming unacceptable. Translating science-based treatments into clinical settings is an important priority in the addictions field and has been the subject of an influential Institute of Medicine report. Substance abuse treatment programs.
  • 2008From: CRCnetBASE
    edited by Steven B. Karch.
    Measuring acute alcohol impairment / Christopher S. Martin -- Update on clinical and forensic analysis of alcohol / Alan Wayne Jones and Derrick J. Pounder -- Post-mortem alcohol: aspects of interpretation / Derrick J. Pounder and Alan Wayne Jones -- Recent advances in biochemical tests for acute and chronic alcohol consumption / Anders Helander and Alan Wayne Jones -- Alcohol determination in point of collection testing / J. Robert Zettl.
  • 2008From: Springer
    Peter J. Adams.
    PART 1: THEORY -- Addiction in Perspective -- Dangerous Consumptions -- Overview of this Book -- Companion Relationships -- A Social World -- Worlds, Paradigms and Assumptions -- The Particle Paradigm -- The Social Paradigm -- Switching to a Social World -- Addiction and Connecting -- Connecting to the World -- Patterns of Fragmentation -- Responding to Addiction -- The Prospect of Change -- Setting Out and Setting Back -- Making it Stick -- PART 2: PROCESSES -- Becoming Intimate -- Living in Relationships -- Intimacy and the "Four Cs" -- Special Considerations -- Quality Intimacy? -- Intimacies in Addictive Contexts -- Intimacy within Addictive Relationships -- Intimacies for Others -- Systems of Intimate Connections -- Intimacy and Power -- Controlling Tactics -- The Myth of Disinhibition -- Violence as a Social Event -- Managed Intimacy -- PART 3: FAMILIES & COMMUNITIES -- Fragmented Lives -- Fragmenting Environments -- How Intimates Respond -- Broader Social Dynamics -- Collective Opportunities -- Empowerment and Connectedness -- Reconnecting Intimates -- Responsibility for Change -- Change Processes -- Guidelines for Effective Collective Action -- Reintegration -- What is Reintegration? -- Six Phases of Reintegration -- Reforming Intimacies -- Enabling Closeness and Compassion -- Domains of Connectedness -- PART 4: APPLICATIONS -- Family Resources -- Social Resources from Inner Power -- Social Resources Offered by Services -- Mobilizing Communities -- Volunteer Networks -- Croatian/Italian Community Clubs -- An Indigenous Approach -- Applications to Practice -- Barriers to Social Inclusive Practice -- Social Engagement -- Social Assessment -- Facilitative Meetings -- Looking Ahead -- Where It Fits -- Future Opportunities
  • 2010From: WHO
    [edited by Jonathan M. Samet and Soon-Young Yoon].
    "This publication contributes to the scientific understanding of gender, women, and tobacco in the context of efforts to control the global tobacco epidemic. Topics covered include determinants of starting to use tobacco; exposure to second-hand smoke; the impact that tobacco use has on health; addiction and cessation; treatment programs; and gender and human rights policy. The publication also addresses national economic policy with regard to tobacco control, international treaties, and strategies for tobacco-free mobilization at the regional and international levels. Special attention is paid to an analysis of policies that affect girls and women throughout the life course. Men's responsibility to protect women against second-hand smoke is also highlighted"--Publisher's description.
    Also available: Print – 2010
  • 2012From: Cambridge
    edited by Audrey R. Chapman.
    "The manner in which genetic research associated with addiction is conducted, interpreted and translated into clinical practice and policy initiatives raises important social, ethical and legal issues. Genetic Research on Addiction fulfils two key aims; the first is to identify the ethical issues and requirements arising when carrying out genetically-based addiction research, and the second is to explore the ethical, legal and public policy implications of interpreting, translating and applying this research. The book describes research guidelines on human protection issues such as improving the informed consent process, protecting privacy, responsibilities to minors and determining whether to accept industry funding. The broader public health policy implications of the research are explored and guidelines offered for developing effective social interventions. Highly relevant for clinicians, researchers, academics and policy-makers in the fields of addiction, mental health and public policy"--Provided by publisher.
  • 2011From: WHO
    "This publication presents a comprehensive perspective on the worldwide, regional and country consumption of alcohol, patterns of drinking, health consequences and policy responses in member states. It represents a continuing effort by WHO to support member states with global information in their efforts to reduce the harmful use of alcohol and its health and social consequences"--Publisher's description.
    Also available: Print – 2011
  • 2014From: WHO
    The Global status report on alcohol and health 2014 presents a comprehensive perspective on the global, regional and country consumption of alcohol, patterns of drinking, health consequences and policy responses in Member States. It represents a continuing effort by the World Health Organization (WHO) to support Member States in collecting information in order to assist them in their efforts to reduce the harmful use of alcohol, and its health and social consequences. The report was launched in Geneva on Monday 12 May 2014 during the second meeting of the global network of WHO national counterparts for implementation of the global strategy to reduce the harmful use of alcohol.--Publisher's description.
    Also available: Print – 2014
  • 2010From: WHO
    The global strategy to reduce the harmful use of alcohol. Setting the scene -- Challenges and opportunities -- Aims and opportunities -- Guiding principles -- National policies and measures -- Policy options and interventions -- Global action : key roles and components -- Implementing the strategy -- Resolution of the sixty-third World Health Assembly (May 2010) WHA63.13 Global Strategy to Reduce the Harmful Use of Alcohol.
    Also available: Print – 2010
  • 2014From: OSO
    Tamyko Ysa, Joan Colom, Adrià Albareda, Anna Ramon, Marina Carrión, Lidia Segura.
  • 2007From: NCI
    edited by Allan Best ... [et al.].
  • 2009From: WHO
    These guidelines review the use of medicines such as methadone, buprenorphine, naltrexone and clonidine in combination with psychosocial support in the treatment of people dependent on heroin or other opioids. Based on systematic reviews of the literature and using the GRADE approach to determining evidence quality, the guidelines contain specific recommendations on the range of issues faced in organizing treatment systems, managing treatment programs and in treating people dependent on opioids.--back cover
    Also available: Print – 2009
  • 2006From: Springer
    edited by Zili Sloboda and William J. Bukoski.
    I: HISTORICAL OVERVIEW: The emerging science of drug abuse prevention / William J. Bukoski -- II: SOCIAL CONTEXTS OF PREVENTION: Effective mass media strategies for drug abuse prevention campaigns / Philip Palmgreen and Lewis Donohew -- Drug abuse prevention curricula in schools / Gilbert J. Botvin and Kenneth W. Griffin -- Dissemination of research-based family intervention for the prevention of substance abuse / Karol L. Kumpfer and Steve Adler -- Peers and the prevention of adolescent drug use -- / E. R. Oetting and R. S. Lynch -- Mobilizing communities to reduce risk for drug abuse: a comparison of two strategies / Michael W. Arthur, Charles D. Ayers, Kelly A. Graham, and J. David Hawkins -- Community-focused drug abuse prevention / Barry M. Kibel and Harold D.Holder -- Drug abuse prevention in the workplace / Royer F. Cook -- Prevention approaches to methadone treatment settings: children of drug abuse treatment clients / Richard F. Catalano, Kevin P. Haggerty, and Randy R. Gainey -- III: PREVENTION AS SOCIAL CONTROL: Drug tests in prevention research / Robert L. DuPont and Keith E. Saylor -- Anti-drug-abuse policies on prevention strategies / Mary Ann Pentz -- IV: THEORETICAL AND EMPIRICAL FOUNDATIONS OF PREVENTION: Forging a relationship between drug abuse epidemiology and drug abuse prevention / Zili Sloboda -- Risk and protective factors of adolescent drug use: implications for prevention programs / Judith S. Brook. David W. Brook, Linda Richter, and Martin Whiteman -- Bridging the gap between substance use prevention theory and practice / Brian R. Flay and John Petraitis -- Preventive intervention targeting precursors / John E. Lochman -- Designing prevention programs: the developmental perspective / Marvin W. Berkowitz and Audrey L. Begun -- V: SPECIAL POPULATIONS: Gender issues in substance abuse prevention / Louise Ann Rohrbach and Joel Milam -- Preventing substance use among Latino youth / Charles R. Martinez, Jr., J. Mark Eddy, and David S. DeGarmo -- African-American substance use epidemiology and prevention issues / William L. Turner and Michael J. Hench -- The effectiveness of alcohol and drug abuse prevention among American-Indian youth / Fred Beauvais and Joseph E. Trimble -- Drug abuse prevention research for Asian and Pacific Islander Americans / W. William Chen -- VI: INTERACTIONS BETWEEN BIOLOGY AND SOCIAL CONTEXT: RISKS FOR MULTIPLE BEHAVIORAL AND MENTAL DISORDERS: Basic science and drug abuse prevention: neuroscience, learning, and personality perspectives / Michael T. Bardo, Thomas Kelly, Donald R. Lynam, and Richard Milich -- Cross-national comparisons of co-morbidities between substance use disorders and mental disorders / Ronald C. Kessler, Sergio Aguilar-Gaxiola, Laura Andrade, Rob Bijl ... [et al.] -- Drug abuse research for high-risk youth / Leona L. Eggert and Brooke P. Randell -- Research designs for family studies / Michael Vanyukov, Howard Moss, and Ralph E. Tarter -- VII: RESEARCH DESIGN, MEASUREMENT, AND DATA ANALYTIC ISSUES: Design principles and their application in preventive field trials / C. Hendricks Brown -- Major data analysis issues in drug abuse prevention research / David P. MacKinnon and James H. Dwyer -- Metholological considerations to prevention research / Linda M. Collins and Brian P. Flaherty -- Prevention program implementation / Steven Schinke and Kristin Cole -- Family management practices: research design and measurement issues / Thomas J. Dishion, Bert Burraston, and Fuzhong Li -- Power analysis models and methods: a latent variable framework for power estimation and analysis / Terry E. Duncan, Susan C. Duncan, and Puzhong Li -- VIII: DRUG ABUSE PREVENTION: A LOOK TO THE FUTURE: Application of computer technology to drug abuse prevention / Kris Bosworth -- Putting science into practice / Gale Held.
  • 2008From: Springer
    edited by Amitava Dasgupta.
    Introduction to therapeutic drug monitoring. -- Monitoring free drug concentration. -- Analytical techniques for measuring concentrations of therapeutic drugs in biological fluids. -- The pre-analytical phase of drug testing: from specimen collection to analysis. -- Effect of hemolysis, high bilirubin, lipemia, paraproteins, and system factors on therapeutic drug monitoring. -- Digoxin: so many interferences and how to eliminate them. -- Interferences with measurement of anticonvulsants. -- Pitfalls in measuring antidepressant drugs. -- Immunosuppressive drugs: pharmacokinetics, preanalytic variables, and analytical considerations. -- Therapeutic drug monitoring in human immunodeficiency virus/acquired immunodeficiency syndrome. -- Pharmacogenetics and personalized medicine: issues and methodology. -- Interference of heterophilic and other antibodies in measurement of therapeutic drugs by immunoassays. -- Drug-herb and drug-food interactions: impact on therapeutic drug monitoring. -- Toxic element testing with clinical specimens. -- Alcohol testing. -- Introduction to drugs of abuse testing. -- Urinary adulterants and drugs of abuse testing. -- Hair, oral fluid, sweat, and meconium testing for drugs of abuse: advantages and pitfalls. -- Abused and designer drugs and how they escape detection. -- Interpretation of amphetamines screening and confirmation testing. -- Clinical false-positive drug test results. -- Providing expert witness for alcohol and positive drugs of abuse test results.
  • 2011From: Springer
    Carl Leukefeld, Thomas P. Gullotta, John Gregrich, editors.
  • 2012From: Wellcome Trust
    edited by C. Overy, L.A. Reynolds and E.M. Tansey.
  • 2014From: ScienceDirect
    edited by Philip Seeman, Bertha Madras.
    "Modern imaging techniques have allowed researchers to non-invasively peer into the human brain and investigate, among many other things, the acute effects and long-term consequences of drug abuse. Here, we review the most commonly used and some emerging imaging techniques in addiction research, explain how the various techniques generate their characteristic images and describe the rational that researchers use to interpret them. In addition, examples of seminal imaging findings are highlighted that illustrate the contribution of each imaging modality to the expansion in our understanding of the neurobiological bases of drug abuse and addiction, and how they can be parlayed in the future into clinical and therapeutic applications"--Provided by publisher.
  • 2011From: Springer
    Michael T. Bardo, Diana H. Fishbein, Richard Milich, editors.
    Part I: Introduction -- Part II: Neurobehavioral approaches for understanding inhibitory control -- Part III: Translating research on inhibitory control to at-risk populations -- PartIV: Translating research on inhibitory control to prevention interventions -- PartV: Conclusion.
  • 2000-From: NCBI Bookshelf
    [Institut National de la Santé et de la Recherche Médicale].
    A collection of syntheses of the international scientific literature and recommendations on public health problems, by Inserm's expert advisory groups.
  • 2009From: CRCnetBASE
    Steven B. Karch.
    Cocaine -- Natural stimulants -- Synthetic stimulants -- Hallucinogens -- Opiates and opioids -- Dissociative anesthetics -- Anabolic steroids -- Solvents -- Marijuana -- Appendix 1: Conversion formulas -- Appendix 2: Blood alcohol concentrations -- Appendix 3: Volume of distribution calculations -- Appendix 4: Normal heart weights.
  • 2011From: Ovid
    Lowinson, Joyce H.; Ruiz, Pedro; Strain, Eric C.
    "A comprehensive, authoritative text on all aspects of substance abuse and addiction medicine. Scientific topics such as the biology of various addictions and all dimensions of clinical treatment and management are addressed by a wide range of leading contributors. Behavioral addictions are addressed also, so the text is not solely devoted to specific substances and their misuse"--Provided by publisher.
  • 2015From: Springer
    Donald R Taylor, MD.
    This text will provide readers with a thorough review of the complex condition of chronic pain and addictions. The book was originally commissioned due to the need in the field for more literature on the topic. This concise pocket book will review epidemiology, clinical features, diagnosis, and medical management of both chronic pain and addiction. Busy healthcare professionals will benefit from this text, which will not only cover the foundation of the management of both conditions and together, but discuss up-to-date national and international treatment guidelines, upcoming therapies and REMS.
  • 2007From: CRCnetBASE
    edited by Tony P. George.
  • 2014From: Springer
    Noeline Latt, Katherine Conigrave, John B. Saunders, E. Jane Marshall, David Nutt ; Edizione italiana a cura di Massimo Clerici ed Ester di Giacomo.
    L'abuso di sostanze può essere alla base di un gran numero di patologie e disturbi psichiatrici, e viene classificato tra i primi quattro fattori di rischio che contribuiscono al carico di malattia globale. Una situazione di dipendenza può infatti complicare un quadro psichiatrico già difficile, poiché si sovrappone ad altri disturbi e talvolta ne prende le forme, rendendo ancora più ardua la valutazione del paziente. Individuare con precisione un disturbo da abuso di sostanze può facilitare la diagnosi clinica, evitare test non necessari e abbreviare la durata del ricovero. Questo volume costituisce una guida pratica e concisa rivolta agli studenti, ai medici e ad altre figure professionali che si confrontano con la moderna medicina della dipendenza. Illustrando una vasta gamma di evidenze, metodi e soluzioni per la gestione del paziente con dipendenza, questa guida fornisce gli strumenti e le conoscenze di base utili a una pratica clinica rapida ed efficace in questo campo.
  • 2010From: WHO
    Mental Health Gap Action Programme, World Health Organization.
    The mhGAP-IG has been developed through an intensive process of evidence review. A WHO Guideline Development Group of international experts conducted systematic reviews to develop evidence-based recommendations. The recommendations were then converted into clearly presented stepwise interventions and then circulated among a wider range of reviewers across the world to include all the diverse contributions. The mhGAP-IG is based on the mhGAP Guidelines on interventions for mental, neurological and substance use disorders (http:// Both documents will be reviewed and updated in 5 years. Any revision and update before that will be made to the online version of the document.--(excerpt, p. 1).
    Also available: Print – 2010
  • 2013From: Springer
    Kenneth Blum, John Femino, Scott Teitelbaum, John Giordano, Marlene Oscar-Berman, Mark Gold.
    Humans are biologically programmed to seek out pleasurable experiences. These experiences are processed in the mesolimbic system, also referred to as the "reward center" of the brain, where a number of chemical messengers work in concert to provide a net release of dopamine in the Nucleus Accumbens. In some genetically predisposed individuals, addiction occurs when the mechanisms of the mesolimbic system are disrupted by the use of various drugs of abuse. Since Alcoholics Anonymous was founded in 1935, it's 12 step program of spiritual and character development has helped countless alcoholics and drug addicts curb their self-destructive behaviors. However, the program was developed at a time when comparatively little was known about the function of the brain and it has never been studied scientifically. This is the first book to take a systematic look at the molecular neurobiology associated with each of the 12 steps and to review the significant body of addiction research literature that is pertinent to the program.
  • 2009From: Springer
    edited by Rick A. Bevins and Anthony R. Caggiula.
    This title draws upon research on the drug widely believed to form the basis of tobacco use and dependence, nicotine. When discussing drug addiction and dependence, an increasing number of scientists are using the concepts of motivation and related constructs and their applications in modifying behavior.
  • 2000-From: Google Books
    Also available: Print – 2000
    Also available: Print – <2002>
  • v. 16-, 2005-From: NCI
  • 2013From: Springer
    Changhai Cui, Lindsey Grandison, Antonio Noronha, editors.
    Rapid advances in understanding neural-immune interactions have far reaching impact on research in many areas of neuroscience. It is becoming increasingly clear that neuroimmune factors modulate a wide range of brain functions and play an important role in development, normal brain function, and CNS dysfunctions, including neurodegenerative diseases, neuropsychiatric disorders and addiction. "Neural.Immune Interaction in Brain Function and Alcohol Related Disorders" integrates emerging knowledge on neural-immune interactions with related key discoveries in alcohol research to provide a comprehensive overview of neuroimmune system in brain function and behavior associated with alcohol use disorders. Readers will benefit from cutting edge insights provided by outstanding, active researchers in the fields of neuroimmune research and alcohol use disorders.
  • 2015From: Springer
    David J. K. Balfour, Marcus R. Munafò, editors.
    The primary purpose of this book and its companion volume The Neuropharmacology of Nicotine Dependence is to explore the ways in which recent studies on nicotine and its role in tobacco addiction have opened our eyes to the psychopharmacological properties of this unique and fascinating drug. While the present volume considers the molecular and genetic factors which influence behavioral responses to nicotine and how these may impact on the role of nicotine in tobacco dependence, the book The Neuropharmacology of Nicotine Dependence focuses on the complex neural and psychological mechanisms that mediate nicotine dependence in experimental animal models and their relationship to tobacco addiction in humans. These volumes will provide readers with a contemporary overview of current research on nicotine psychopharmacology and its role in tobacco dependence from leaders in this field of research and will hopefully prove valuable to those who are developing their own research programmes in this important topic. CTBN Vol 23 The Behavioral Genetics of Nicotine and Tobacco The primary purpose of this book and its companion volume The Neuropharmacology of Nicotine Dependence is to explore the ways in which recent studies on nicotine and its role in tobacco addiction have opened our eyes to the psychopharmacological properties of this unique and fascinating drug. While the present volume considers the molecular and genetic factors which influence behavioral responses to nicotine and how these may impact on the role of nicotine in tobacco dependence, the book The Neuropharmacology of Nicotine Dependence focuses on the complex neural and psychological mechanisms that mediate nicotine dependence in experimental animal models and their relationship to tobacco addiction in humans. These volumes will provide readers with a contemporary overview of current research on nicotine psychopharmacology and its role in tobacco dependence from leaders in this field of research and will hopefully prove valuable to those who are developing their own research programmes in this important topic.
  • 2016From: Oxford Medicine Online
    edited by Alan C. Swann, F. Gerard Moeller, Marijn Lijffijt.
    Beyond drugs : addictions in the context of recurrent/progressive psychiatric illness / Alan C. Swann -- Behavioral mechanisms in addiction / Margaret C. Wardle, Jin H. Yoon, Anka A. Vujanovic, Michael F. Weaver, Scott D. Lane, and Joy M. Schmitz -- The biology of nicotine addiction and factors that differentiate youth who smoke from those who do not / Felicia R. Carey and Anna V. Wilkinson -- Resilience and opiate misuse / Sameer Hassamal, Divya Ramesh, and F. Gerard Moeller -- Alcohol-related disorders : adaptations and progression to disordered drinking / Therese A. Kosten, Colin Haile, Marijn Lijffijt, and Alan C. Swann -- The neurobiology of behavioral sensitization / Jeffery D. Steketee -- Stress and addiction / Marijn Lijffijt -- The neurobiology of behavioral addictions : sexual addiction / Donald L. Hilton Jr., Stefanie Carnes, and Todd L. Love -- Norepinephrine as a therapeutic target for cocaine-use disorder / Colin N. Haile, Thomas F. Newton, and Thomas R. Kosten -- Cannnabis, endocannabinoids, and mechanisms of addiction / Christopher Rodgman and Christopher D. Verrico -- Cocaine addiction therapy pharmacogenetics / David A. Nielsen -- Increasing the information yield from clinical trials in addictions : Bayesian statistics, adaptive designs, and biomarker evaluation / Charles Green, Robert Suchting, Nuvan Rathnayaka, Margaret Wardle, and Joy M. Schmitz -- Mechanisms of sensitization to stress, affective episodes, and abused substances : implications for treatment and prevention / Robert M. Post.
  • 2006From: ScienceDirect
    George F. Koob, Michel Le Moal.
    What is addiction? -- Animal models of drug addiction -- Psychostimulants -- Opioids -- Alcohol -- Nicotine -- Cannabinoids -- Imaging -- Neurobiological theories of addiction -- Drug addiction : transition from neuroadaptation to pathophysiology.
  • 2008From: CRCnetBASE
    edited by Steven B. Karch.
    The dopamine transporter and addiction / William M. Meil and John W. Boja -- Neurochemistry of nicotine dependence / Darlene H. Brunzell -- Neurochemical substrates of habitual tobacco smoking / Irina Esterlis, Suchitra Krishnan-Sarin, and Julie K. Staley -- Neurochemical and neurobehavioral consequences of methamphetamine abuse / Colin N. Haile -- Neurochemical adaptations and cocaine dependence / Kelly P. Cosgrove and Julie K. Staley -- Neuropsychiatric consequences of chronic cocaine abuse / Deborah C. Mash -- Neurobiology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") / Michael H. Baumann and Richard B. Rothman.
  • 2015From: Springer
    Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer, editors.
    This book reviews the imaging features associated with selected classes of pharmaceuticals and drugs on brain, head and neck, and spine and explains the implications of the imaging findings for the neuroradiologist and the clinician. Some agents produce characteristic abnormalities with distinctive imaging features, while others have a spectrum of manifestations on imaging. Still further agents produce rather nonspecific changes on imaging, requiring a differential diagnosis. In this book, informative cases are depicted by rich images, with concise accompanying explanatory text that reviews the class of agent and the mechanism of action and discusses image interpretation and its significance.
  • 2015From: Springer
    David J.K. Balfour, Marcus R. Munafó, editors.
    Imaging Tobacco Smoking with PET and SPECT -- Behavioral Mechanisms Underlying Nicotine Reinforcement -- The Role of Mesoaccumbens Dopamine in Nicotine Dependence -- Nicotine Withdrawal -- Neurobiologal bases of cue- and nicotine-induced reinstatement of nicotine seeking -- Psychiatric disorders as vulnerability factors for nicotine addiction: What have we learned from animal models?.
  • 2016From: ScienceDirect
    edited by Hamed Ekhtiari and Martin Paulus.
    Preface: Neuroscience for addiction medicine: from prevention to rehabilitation -- Part 1: Neuroscience constructs for addiction medicine. Neuroscience of resilience and vulnerability for addiction medicine: from genes to behavior -- Drug-induced neurotoxicity in addiction medicine: from prevention to harm reduction -- Stress psychobiology in the context of addiction medicine: from drugs of abuse to behavioral addictions -- Reinforcement principles for addiction medicine; from recreational drug use to psychiatric disorder -- Neuroscience of attentional processes for addiction medicine: from brain mechanisms to practical considerations -- Neuroscience of learning and memory for addiction medicine: from habit formation to memory reconsolidation -- Neuroscience of drug craving for addiction medicine: from circuits to therapies -- Response inhibition and addiction medicine: from use to abstinence -- Neuroscience of inhibition for addiction medicine: from prediction of initiation to prediction of relapse -- Part 2: Drugs and behaviours for addiction medicine. Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications -- Neuroscience of alcohol for addiction medicine: neurobiological targets for prevention and intervention in adolescents -- Neuroscience of opiates for addiction medicine: from stress-responsive systems to behavior -- Opioid neuroscience for addiction medicine: from animal models to FDA approval for alcohol addiction -- Competing neurobehavioral decision systems theory of cocaine addiction: from mechanisms to therapeutic opportunities -- Clinical neuroscience of amphetamine-type stimulants: from basic science to treatment development -- Behavioral addictions in addiction medicine: from mechanisms to practical considerations -- Neural systems implicated in obesity as an addictive disorder: from biological to behavioral mechanisms.
  • 2016From: ScienceDirect
    edited by Hamed Ekhtiari and Martin Paulus.
    Preface: Neuroscience for addiction medicine: from prevention to rehabilitation -- Part I: Neuroscience methods for addiction medicine. Animal models for addiction medicine: from vulnerable phenotypes to addicted individuals -- Animal models of drug relapse and craving: from drug priming-induced reinstatement to incubation of craving after voluntary abstinence -- Computational modeling for addiction medicine: from cognitive models to clinical applications -- Electrophysiology for addiction medicine: from methodology to conceptualization of reward deficits -- Neurocognitive rehabilitation for addiction medicine: from neurophysiological markers to cognitive rehabilitation and relapse prevention -- Structural imaging for addiction medicine: from neurostructure to neuroplasticity -- Functional neuroimaging for addiction medicine: from mechanisms to practical considerations -- Resting state functional connectivity analysis for addiction medicine: from individual loci to complex networks -- PET imaging for addiction medicine: from neural mechanisms to clinical considerations -- Genetic imaging consortium for addiction medicine: from neuroimaging to genes -- Part II: Neuroscience for interventions in addiction medicine. Human pharmacology for addiction medicine: from evidence to clinical recommendations -- Emerging targets for addiction neuropharmacology: from mechanisms to therapeutics -- Cognitive interventions for addiction medicine: understanding the underlying neurobiological mechanisms -- Adolescent psychotherapy for addiction medicine: from brain development to neurocognitive treatment mechanisms -- Cognitive neuroscience of cognitive retraining for addiction medicine: from mediating mechanisms to questions of efficacy -- Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders: from cognitive improvement to relapse prevention -- Noninvasive brain stimulation for addiction medicine: from monitoring to modulation -- What the alcohol doctor ordered from the neuroscientist: theragnostic biomarkers for personalized treatments -- What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses.
  • 2017From: ScienceDirect
    edited by Victor R. Preedy.
  • 1988From: NLM
    Also available: Print – 1988
  • 2013From: ScienceDirect
    edited by Paul Dargan, David M. Wood.
  • 2009From: Springer
    Reginald L. Dean III, Edward J. Bilsky, S. Stevens Negus, editors.
  • 2008From: CRCnetBASE
    edited by Steven B. Karch.
    The criminalistics of controlled substances / Joseph P. Bono -- Overview of pathology of drug abuse : scene of death and the autopsy / Charles V. Wetli -- Heart disease / Renu Virmani, Allen P. Burke, Andrew Farb -- Vascular effects of substance abuse / Frank D. Kolodgie, Allen P. Burke, Jagat Narula, Florabel G. Mullick, Renu Virmani -- Myocardial alterations in drug abusers / Steven B. Karch -- Valvular heart disease / Michael D. Bell -- Lung disease / Michael D. Bell -- Disorders of the central nervous system / Michael D. Bell -- Toxicogenetics in drug abuse : pharmacogenomics for toxicology / Robert M. White, Steven H.Y. Wong -- Toxicogenetics in drug abuse : heritable channelopathies and myopathies / Kathryn A. Glatter, Jonica Calkins, Sanjay J. Ayirookuzhi.
  • 2012From: Springer
    Ethan O. Bryson, Elizabeth A. M. Frost, editors ; foreword by David L. Reich.
  • 2012From: CRCnetBASE
    [edited by] Amitava Dasgupta, Loralie J. Langman.
    Ch. 1. Pharmacogenomics principles of alcohol and DOA / Christine L.H. Snozek and Loralie J. Langman -- ch. 2. Alcohol : use and abuse / Amitava Dasgupta -- ch. 3. Slate and trait makers of alcohol abuse / Joshua Bornhorst ... [et al.] -- ch. 4. Introduction to drugs of abuse / Larry Broussard and Catherine Hammett-Stabler -- ch. 5. Pharmacogenomics of amphetamine and related drugs / Steven C. Kazmierczak -- ch. 6. Pharmacogenomics of cocaine / Loralie J. Langman and Christine L.H. Snozek -- ch. 7. Genetic aspect of marijuana metabolism and abuse / Pradip Datta -- ch. 8. Genetic aspect of opiate metabolism and addiction / Jorge L. Sepulveda -- ch. 9. Pharmacogenomics aspects of addiction treatment / F. Gerard Moeller -- ch. 10. Methodologies in pharmacogenetics testing / Jorge L. Sepulveda.

Access restricted to Stanford community

Shortcut to Licensed Content

Lane Gateway to Licensed Content

TO INSTALL, DRAG THIS BUTTON to your browser Bookmarks or Tools Bar.

What is it?

Lane Gateway to Licensed Content

Bookmark on Other Websites

Bookmark on Lane

  • TO INSTALL, RIGHT CLICK this button.
  • Select "Add to Favorites" (click “Continue” if you see a security alert)
  • From the "Create in" menu, select “Favorites Bar” (IE8, IE9) to install
  • Once installed it will look like this
  • Click "Bookmark on Lane" to bookmark any webpage
  • Your saved bookmark will appear on this page

What is it?

Derived from Current Medical Diagnosis & Treatment, AccessMedicine's Quick Medical Diagnosis & Treatment provides topic reviews with key diagnostic and treatment features for more than 500 diseases.

A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more.

Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.

MicroMedex: Premier pharmaceutical information source containing multiple databases and drug reference tools. Of particular value is DRUGDEX Evaluations, one of the most comprehensive drug sources available.DynaMed Plus is a clinical information resource used to answer questions quickly at the point-of-care. Easy-to-interpret Levels of Evidence help clinicians rapidly determine the quality of the available evidence.

Biomedical and pharmacological abstracting and indexing database of published literature, by Elsevier. Embase® contains over 32 million records from over 8,500 currently published journals (1947-present) and is noteworthy for its extensive coverage of the international pharmaceutical and alternative/complementary medicine literature.

Scopus is the largest abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings.A drug information resource containing: American Hospital Formulary System (AHFS), drug formulary for Lucile Packard Children's Hospital (LPCH) and Stanford Hospital & Clinics (SHC), Lexi-Drugs (adverse reactions, dosage and administration, mechanism of action, storage, use, and administration information), Lexi-Calc, Lexi-ID, Lexi-I.V. Compatibility (King Guide), Lexi-Interact, and Lexi-PALS.Cumulative Index to Nursing and Allied Health Literature (CINAHL) contains coverage of nursing and allied health literature.A knowledge database that provides access to topic reviews based on over 6000 clinically relevant articles. The evidence-based content, updated regularly, provides the latest practice guidelines in 59 medical specialties.Provides critical assessments of systematic reviews compiled from a variety of medical journals.Selects from the biomedical literature original studies and systematic reviews that are immediately clinically relevant and then summarizes these articles in an enhanced abstract with expert commentary.

Multidisciplinary coverage of over 10,000 high-impact journals in the sciences, social sciences, and arts and humanities, as well as international proceedings coverage for over 120,000 conferences.

Includes cited reference searching, citation maps, and an analyze tool.

Features systematic reviews that summarize the effects of interventions and makes a determination whether the intervention is efficacious or not.

Cochrane reviews are created through a strict process of compiling and analyzing data from multiple randomized control trials to ensure comprehensiveness and reliability.

Provides systematic coverage of the psychological literature from the 1800s to the present through articles, book chapters and dissertations.BMJ Clinical Evidence. A clinical information tool built around systematic reviews summarizing the current state of knowledge about prevention and treatment of clinical conditions.PIER (Physicians' Information and Education Resource) is a Web-based decision-support tool designed for rapid point-of-care delivery of up-to-date, evidence-based guidance for primary care physicians.Cochrane Central Register of Controlled Trials (CENTRAL) provides access to 300,000 controlled trials that have been identified the Cochrane Collaboration.Provides drug information targeted for patients.A continually updating drug monograph.The National Guideline Clearinghouse (NGC): A comprehensive database of evidence-based clinical practice guidelines and related documents.MedlinePlus: A repository of health information from the National Library of Medicine. Links are from trusted sites. No advertising, no endorsement of commercial companies or productsLPCH CareNotes via MicroMedex: Patient education handouts customized by LPCH clinical staffMicromedex Lab Advisor: Evidence based laboratory test informationA drug database organized by generic name, trade name and drug class.LPCH / Stanford Hospital Formulary.A goldmine of trusted consumer health information from the world's largest medical library.A trusted source of expert advice for and about kids, providing the information necessary to help patients and parents understand their unique needs.Provides patient handouts from the American Academy of Family Physician.Access to the Stanford Health Library for patients.Lane provides access to over 5,000 eBooks many of which provide helpful background material that will prepare you to better tackle primary literature.

Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities.

In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.

A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.

A web-based, decision support system for infectious diseases, epidemiology, microbiology and antimicrobial chemotherapy. The database, updated weekly, currently includes 337 diseases, 224 countries, 1,147 microbial taxa and 306 antibacterial (-fungal, -parasitic, -viral) agents and vaccines.

Over 10,000 notes outline the status of specific infections within each country.

Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.

Provides online, full-text access to Springer's journal titles as well as journals from other publishers.

Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.

Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.

Stanford Medicine

Lane Medical Library